GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biosynex SA (FRA:0DL) » Definitions » YoY EBITDA Growth

Biosynex (FRA:0DL) YoY EBITDA Growth : 247.26% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biosynex YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Biosynex's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 247.26%.

Biosynex's EBITDA per Share for the six months ended in Jun. 2024 was €0.51.


Biosynex YoY EBITDA Growth Historical Data

The historical data trend for Biosynex's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosynex YoY EBITDA Growth Chart

Biosynex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 462.79 1,885.12 142.53 -64.45 -111.59

Biosynex Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.59 -104.46 -96.60 -272.90 247.26

Biosynex YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Biosynex's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.48-4.142)/ | 4.142 |
=-111.59 %

Biosynex's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(0.507-0.146)/ | 0.146 |
=247.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosynex YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Biosynex's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosynex Business Description

Traded in Other Exchanges
Address
22 Boulevard Sebastien Brant, Illkirch, FRA, 67400
Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.

Biosynex Headlines

No Headlines